Recent Articles
The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science
An Emory study is recruiting 800 people who faced post-psychedelic challenges, to learn what recovery actually takes.
By Josh Lipson, PhD and Roman Palitsky, MDiv, PhD
Filter
Psychedelic Policy Briefing: Week of July 27th, 2026
The House voted to extend the Pentagon’s psychedelic research program through 2033, then blocked a…
By Jack Gorsline
Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness
Douglas Wingate, a Doctor of Traditional Chinese Medicine and licensed Oregon psilocybin facilitator, maps the…
By Douglas S. Wingate, DTCM, L.Ac.
Psychedelic Policy Briefing: Week of July 20th, 2026
This week in psychedelic policy: Texas moves ahead with state-funded ibogaine trials, Eli Lilly buys…
By Jack Gorsline
What Is Metaprogramming? A Practitioner’s Introduction
Ketamine-assisted therapist Rachel Turetzky explains metaprogramming: John Lilly’s term for consciously rewriting the beliefs that…
By Rachel Turetzky, PhD, CYT, MP-MPr
Psychedelic Policy Briefing: Week of July 13th, 2026
Massachusetts advances a psychedelic therapy pilot program, the FDA finalizes its psychedelic trial guidance and…
By Jack Gorsline
The Rush for Iboga Looks Different from Gabon
Gabonese civil servant and environmental lawyer Georges Gassita on what the ibogaine rush looks like…